Not applicableStudy completedNCT01267942
What this trial is testing
Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Enhancin in Prevention of Postadenotonsillectomy Morbidity.
Who this might be right for
Adenotonsillar Hypertrophy,Under 12 Years.
University of Nairobi 126